Complete genome sequence of Limosilactobacillus reuteri strain iVE-9, isolated from the fecal sample of a healthy human
Mallory J. Van Haute, Katherine Chacón-Vargas, Shara R. P. Yumul, Chloe M. Christensen, Robert Hutkins, Thomas A. Auchtung
TL;DR
This paper reports the full genome of a L. reuteri strain from a human fecal sample, highlighting its potential health benefits.
Contribution
The complete genome sequence of L. reuteri iVE-9 is newly presented with its encoded beneficial metabolic traits.
Findings
The genome encodes production of exopolysaccharides and B vitamins.
It includes genes for bacteriocin and gamma-aminobutyric acid synthesis.
The strain produces indole-3-lactic acid, suggesting probiotic potential.
Abstract
Limosilactobacillus reuteri inhabits the gastrointestinal tract of a variety of hosts. Here, we present the complete genome sequence of a human isolate, L. reuteri iVE-9, that encodes for several potentially beneficial metabolic traits, including production of exopolysaccharides, B vitamins, a bacteriocin, indole-3-lactic acid, and gamma-aminobutyric acid.
Genes, proteins, chemicals, diseases, species, mutations and cell lines named across the full text — each resolved to its canonical identifier and authoritative record.
Click any figure to enlarge with its caption.
Figure 1Peer Reviews
No public reviews on file for this paper yet. If you reviewed it on a platform where reviews are public (OpenReview, ICLR, NeurIPS, ICML), you can paste yours below so the community can read it here.
Videos
No videos yet. Explain this paper in a talk, walkthrough, or lecture? Add one.
Taxonomy
TopicsProbiotics and Fermented Foods · Infant Nutrition and Health · Bacterial Genetics and Biotechnology